Helmy Eltoukhy Guardant Health, Inc. (GH) insider trading activity

Helmy Eltoukhy is Co-Chief Executive Officer of Guardant Health, Inc.. Currently has a direct ownership of 2.06 Million shares of GH, which is worth approximately $195 Million. The most recent transaction as insider was on Jan 01, 2026, when has been sold 10,788 shares (Common Stock) at a price of $102.14 per share, resulting in proceeds of $1,101,886. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.06M

3.51% 3M change

12.64% 12M change

Total Value Held $195 Million

Helmy Eltoukhy Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 01 2026	SELL Payment of exercise price or tax liability	$1,101,886 $102.14 p/Share	10,788 Reduced 0.52%	2,062,726 Common Stock
Jan 01 2026	BUY Exercise of conversion of derivative security	-	23,997 Added 1.14%	2,073,514 Common Stock
Dec 31 2025	SELL Payment of exercise price or tax liability	$249,323 $102.14 p/Share	2,441 Reduced 0.12%	2,049,517 Common Stock
Dec 31 2025	BUY Exercise of conversion of derivative security	-	4,815 Added 0.23%	2,051,958 Common Stock
Dec 15 2025	SELL Open market or private sale	$9,410,609 $103.91 p/Share	90,565 Reduced 4.24%	2,047,143 Common Stock
Oct 01 2025	SELL Payment of exercise price or tax liability	$761,949 $62.65 p/Share	12,162 Reduced 0.57%	2,137,708 Common Stock
Oct 01 2025	BUY Exercise of conversion of derivative security	-	23,997 Added 1.1%	2,149,870 Common Stock

Sep 30 2025	SELL Payment of exercise price or tax liability	$152,451 $62.48 p/Share	2,440 Reduced 0.11%	2,125,873 Common Stock
Sep 30 2025	BUY Exercise of conversion of derivative security	-	4,814 Added 0.23%	2,128,313 Common Stock
Sep 09 2025	SELL Open market or private sale	$17,904,000 $59.68 p/Share	300,000 Reduced 12.38%	2,123,499 Common Stock
Jul 01 2025	SELL Payment of exercise price or tax liability	$616,735 $50.71 p/Share	12,162 Reduced 0.5%	2,423,499 Common Stock
Jul 01 2025	BUY Exercise of conversion of derivative security	-	23,997 Added 0.98%	2,435,661 Common Stock
Jun 30 2025	SELL Payment of exercise price or tax liability	$127,029 $52.04 p/Share	2,441 Reduced 0.1%	2,411,664 Common Stock
Jun 30 2025	BUY Exercise of conversion of derivative security	-	4,815 Added 0.2%	2,414,105 Common Stock
Apr 01 2025	SELL Payment of exercise price or tax liability	$516,562 $42.47 p/Share	12,163 Reduced 0.5%	2,409,290 Common Stock
Apr 01 2025	BUY Exercise of conversion of derivative security	-	23,998 Added 0.98%	2,421,453 Common Stock
Mar 31 2025	SELL Payment of exercise price or tax liability	$103,944 $42.6 p/Share	2,440 Reduced 0.1%	2,397,455 Common Stock
Mar 31 2025	BUY Exercise of conversion of derivative security	-	4,814 Added 0.2%	2,399,895 Common Stock
Mar 14 2025	SELL Payment of exercise price or tax liability	$1,494,845 $42.89 p/Share	34,853 Reduced 1.43%	2,395,081 Common Stock
Mar 14 2025	BUY Exercise of conversion of derivative security	-	68,769 Added 2.75%	2,429,934 Common Stock
Jan 01 2025	SELL Payment of exercise price or tax liability	$1,323,089 $30.55 p/Share	43,309 Reduced 1.8%	2,361,165 Common Stock
Jan 01 2025	BUY Exercise of conversion of derivative security	-	94,555 Added 3.78%	2,404,474 Common Stock
Dec 31 2024	SELL Payment of exercise price or tax liability	$177,464 $30.55 p/Share	5,809 Reduced 0.25%	2,309,919 Common Stock
Dec 31 2024	BUY Exercise of conversion of derivative security	-	11,462 Added 0.49%	2,315,728 Common Stock
Sep 30 2024	SELL Payment of exercise price or tax liability	$133,258 $22.94 p/Share	5,809 Reduced 0.25%	2,304,266 Common Stock

Helmy Eltoukhy

Co-Chief Executive Officer

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GH shares.

Notify only if

Value

Insider Trading

Get notified when an Guardant Health, Inc. insider buys or sells GH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Guardant Health, Inc.

Track Activities on GH

Account